Brokerages Set Avantor, Inc. (NYSE:AVTR) Price Target at $27.38

Shares of Avantor, Inc. (NYSE:AVTR - Get Free Report) have been given an average recommendation of "Moderate Buy" by the thirteen analysts that are currently covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $27.38.

Several research analysts have issued reports on AVTR shares. Wells Fargo & Company dropped their target price on Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Monday, October 28th. UBS Group reissued a "neutral" rating and issued a $25.00 price objective (down previously from $29.00) on shares of Avantor in a report on Friday. Barclays reduced their target price on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating for the company in a report on Friday, October 25th. Robert W. Baird cut their price objective on shares of Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a research report on Monday, October 28th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and issued a $34.00 target price on shares of Avantor in a report on Thursday, September 26th.

Institutional Investors Weigh In On Avantor

Several institutional investors and hedge funds have recently modified their holdings of AVTR. Whalen Wealth Management Inc. purchased a new stake in shares of Avantor in the fourth quarter worth about $566,000. Nisa Investment Advisors LLC increased its stake in Avantor by 917.2% in the 4th quarter. Nisa Investment Advisors LLC now owns 20,700 shares of the company's stock worth $436,000 after acquiring an additional 18,665 shares during the last quarter. Perpetual Ltd boosted its position in shares of Avantor by 38.7% during the 4th quarter. Perpetual Ltd now owns 1,766,882 shares of the company's stock valued at $37,228,000 after acquiring an additional 493,408 shares during the last quarter. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Avantor by 99.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock valued at $26,000 after purchasing an additional 625 shares in the last quarter. Finally, UMB Bank n.a. increased its position in Avantor by 56.3% in the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock worth $63,000 after purchasing an additional 1,074 shares during the last quarter. Institutional investors own 95.08% of the company's stock.

Avantor Stock Performance

Avantor stock traded down $0.43 during midday trading on Monday, reaching $22.14. 6,042,606 shares of the company traded hands, compared to its average volume of 3,101,021. Avantor has a 12 month low of $19.59 and a 12 month high of $28.00. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The business has a 50 day moving average of $21.45 and a two-hundred day moving average of $23.39. The firm has a market capitalization of $15.07 billion, a price-to-earnings ratio of 48.13, a price-to-earnings-growth ratio of 3.42 and a beta of 1.28.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.